drugset / Trial / NCT03982238

Effects of Hypoglycemic Drugs on Testosterone Levels in Type 2 Diabetes Patients

NCT03982238

Phase 4 Completed 74 enrolled Majianhua
RandomizedParallel-groupOpen-labelTreatment

Summary

The study will assess the total testosterone and sex hormone-binding globulin levels in men with type 2 diabetes before and after continuous subcutaneous insulin infusion and hypoglycemic drugs treatment.

Timeline

Start
2019-06-15
Primary completion
2019-11-15
Completion
2019-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dapagliflozin Small molecule
Subject Metformin Small molecule 1000 mg Oral
Comparator Insulin Protein / enzyme biologic Subcutaneous